Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
暂无分享,去创建一个
G. Johannsson | M. Andersen | A. J. van der Lely | D. Maiter | P. Burman | Å. Rasmussen | C. Høybye | O. Ragnarsson | D. Bengtsson | K. Berinder | M. Petersson | H. Schrøder | U. Feldt ‐Rasmussen